29.97
Damora Therapeutics Inc (DMRA) 最新ニュース
Damora Therapeutics, Inc. Common Stock (DMRA) Stock Trends and Sentiment 2026 - MarketBeat
Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026 - MarketBeat
Price to sales forward of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView
Damora awards 453,500 stock options to nine new hires - Stock Titan
RBC Capital Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Damora Therapeutics, Inc.(NasdaqCM:DMRA) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Damora Therapeutics, Inc.(NasdaqCM: DMRA) added to Russell 2500 Growth Benchmark - marketscreener.com
Damora Therapeutics, Inc.(NasdaqCM: DMRA) added to Russell 2000 Index - marketscreener.com
Damora Therapeutics (DMRA) Is Up 6.2% After Broad Russell Index Additions Has The Bull Case Changed? - simplywall.st
Damora Therapeutics, Inc. Actuals & Estimates (NASDAQ:DMRA) - TradingView
Damora Therapeutics, Inc.(NasdaqCM: DMRA) added to Russell 2000 Value Benchmark - marketscreener.com
Damora Therapeutics, Inc.(NasdaqCM: DMRA) added to Russell 2000 Growth Benchmark - marketscreener.com
Damora Therapeutics, Inc.(NasdaqCM: DMRA) added to Russell 3000E Growth Benchmark - marketscreener.com
Damora Therapeutics, Inc.(NasdaqCM: DMRA) added to Russell 3000E Value Benchmark - marketscreener.com
Damora Therapeutics Rises as Traders Focus on Near-Term Pipeline Catalysts - Quiver Quantitative
Damora Therapeutics, Inc. Common Stock (DMRA) Institutional Ownership 2026 - MarketBeat
DMRA Forecast — Price Target — Prediction for 2027 - TradingView
Damora Therapeutics, Inc. Common Stock (DMRA) Stock Chart and Price History 2026 - MarketBeat
Form 144 Damora Therapeutics For: 22 June By Investing.com - Investing.com India
DMRA (NASDAQ: DMRA) Form 144 lists option-based sales to Maxim Group - Stock Titan
Damora Therapeutics (DMRA) Slips 0.89% as Stock Holds Above Key SupportOn Balance Volume - dars.gov.et
Damora Therapeutics, Inc. Common Stock (DMRA) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Damora Therapeutics Announces Results of 2026 Annual Meeting - TipRanks
DMRA: All proposals passed, including director elections and auditor ratification, with strong shareholder support - TradingView
Damora Therapeutics Inc Annual Shareholders Meeting Transcript - GuruFocus
Guggenheim Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $40 - Moomoo
DMRA Q1 2026 Earnings: EPS Misses Estimates as Clinical Costs WeighEBITDA Margin Trends - newsline.com
DMRA Reiterates by Wedbush -- Price Target Maintained at $35 - GuruFocus
DMRA Initiated Coverage by HC Wainwright & Co. -- Price Target S - GuruFocus
Damora Therapeutics, Inc. Common Stock (DMRA) Earnings Date and Reports 2026 - MarketBeat
大文字化:
|
ボリューム (24 時間):